Ledger.Open graph →
SEC Form D · filed November 1, 2018

Phoenix Life Sciences International Limited

Offering
$100.0M
Sold
Exemption
Rule 506(b)
Industry
Other Health Care
Location
DENVER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Martin H. Tindall · Denver, COExec · DirectorMartin H. Tindall · Denver, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗